One Health Platform Phoreus Biotechnology's Branched Amphipathic Peptide Capsule platform enables substantially improved delivery for vaccines, cancer therapies, antibiotics and biopesticides, unlocking licensing and co-development opportunities with vaccine developers, oncology programs and animal, plant and environmental health products.

Strategic Partnerships Position the company for partnerships with mid-sized pharma, contract research organizations and biotech startups that need advanced peptide delivery to boost efficacy and safety in biologics and vaccines, including research collaborations and early manufacturing engagements.

Regional Advantage Based in Olathe, Kansas, Phoreus can leverage regional manufacturing, pilot development capabilities and proximity to North American customers to accelerate clinical progression and reduce supply chain risk for partners.

Investor Signals Historical awards and seed funding indicate market credibility and investor interest, which can support licensing negotiations, sponsored research deals and milestone based collaborations with larger biotech players.

Market Scope The broad One Health focus creates multiple cross sector sales routes across human and animal health, agriculture and environmental applications, enabling diversified customer targets from pharmaceutical and veterinary firms to plant protection companies.